gp100 (209-217)

Melanocyte protein PMEL;gp100

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
gp100 (209-217)(CAS 181477-43-0)

CAT No: ta-023

CAS No:181477-43-0

Synonyms/Alias:Disomotide;181477-43-0;Disomotide [USAN:INN];UNII-8028PPX4PM;disomotida;MPS 22;MPS-22;8028PPX4PM;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoic acid;DTXSID50171158;Gp100:209-217(210m) peptide;Gp-100:209-217(210m) peptide;(186-L-Methionine)melanocyte protein Pmel 17 (human melanoma-associated ME20 antigen)-(185-193)-peptide;L-Valine, L-isoleucyl-L-methionyl-L-alpha-aspartyl-L-glutaminyl-L-valyl-L-prolyl-L- phenylalanyl-L-seryl-;Disomotide [USAN];disomotidum;DISOMOTIDE [INN];DISOMOTIDE [WHO-DD];CHEMBL263429;DTXCID4093649;BDBM50409410;FM109412;HY-105039;Q27269103;H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH; H-IMDQVPFSV-OH;(Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) trifluoroacetate salt;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-ALPHA-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C47H74N10O14S
M.W/Mr.
1035.2
Sequence
One Letter Code:IMDQVPFSV
Three Letter Code:H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH
Areas of Interest
Antigen-presenting Cells; Cancer Research
Source#
Homo sapiens (human)
Epitope
209-217
Restricting HLA
HLA-A2
InChI
InChI=1S/C47H74N10O14S/c1-8-26(6)36(49)45(68)51-29(18-20-72-7)39(62)52-31(22-35(60)61)42(65)50-28(16-17-34(48)59)40(63)55-37(24(2)3)46(69)57-19-12-15-33(57)44(67)53-30(21-27-13-10-9-11-14-27)41(64)54-32(23-58)43(66)56-38(25(4)5)47(70)71/h9-11,13-14,24-26,28-33,36-38,58H,8,12,15-23,49H2,1-7H3,(H2,48,59)(H,50,65)(H,51,68)(H,52,62)(H,53,67)(H,54,64)(H,55,63)(H,56,66)(H,60,61)(H,70,71)/t26-,28-,29-,30-,31-,32-,33-,36-,37-,38-/m0/s1
InChI Key
BDQMCYCLZBSYJZ-BBXCZNCNSA-N
References
Kfir Oved; Cancer Immunol Immunother 2005

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisEpitope Mapping ServicesCustom Conjugation ServicePeptide Modification ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide CDMOPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers